AB Corporate Bond ETF (NASDAQ:EYEG – Get Free Report) shares passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $33.68 and traded as high as $33.74. AB Corporate Bond ETF shares last traded at $33.7210, with a volume of 122 shares.
AB Corporate Bond ETF Price Performance
The company has a market capitalization of $26.98 million, a P/E ratio of -20.07 and a beta of 0.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.07 and a quick ratio of 3.07. The firm’s 50-day moving average is $33.68 and its 200-day moving average is $34.78.
AB Corporate Bond ETF Increases Dividend
The firm also recently disclosed a monthly dividend, which was paid on Thursday, November 5th. Stockholders of record on Monday, November 2nd were given a dividend of $0.1460 per share. This represents a $1.75 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Monday, November 2nd. This is a positive change from AB Corporate Bond ETF’s previous monthly dividend of $0.1367. AB Corporate Bond ETF’s payout ratio is presently -102.38%.
About AB Corporate Bond ETF
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Further Reading
- Five stocks we like better than AB Corporate Bond ETF
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
Receive News & Ratings for AB Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.
